Philip D. Hall
- Co-authors
- Mark FensterThomas G. OlsenDebra Frei‐LahrDonald R. FlemingJ BlackBayard L. PowellRonald B. GartenhausArthur E. Frankel
- Topics
- Chronic Lymphocytic Leukemia Research (2 papers)Innovations in Medical Education (2 papers)Pharmaceutical Practices and Patient Outcomes (2 papers)
- Cited by
- OncologyDermatologyImmunology
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Philip D. Hall
13 papers receiving 291 citations
Peers
Comparison fields: 5 of 86
- Oncology 127
- Immunology 66
- Molecular Biology 51
- Epidemiology 44
- Pathology and Forensic Medicine 43
Countries citing papers authored by Philip D. Hall
This map shows the geographic impact of Philip D. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Hall more than expected).
Fields of papers citing papers by Philip D. Hall
This network shows the impact of papers produced by Philip D. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Hall. The network helps show where Philip D. Hall may publish in the future.
Co-authorship network of co-authors of Philip D. Hall
This figure shows the co-authorship network connecting the top 25 collaborators of Philip D. Hall. A scholar is included among the top collaborators of Philip D. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip D. Hall. Philip D. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | Blinatumomab: A Step Forward in the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia | 2 |
| 4 | 9 | |
| 5 | 3 | |
| 6 | 94 | |
| 7 | 36 | |
| 8 | A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia. | 60 |
| 9 | 19 | |
| 10 | 7 | |
| 11 | 17 | |
| 12 | 0 | |
| 13 | 32 | |
| 14 | 7 | |
| 15 | 10 |
About Philip D. Hall
Philip D. Hall is a scholar working on Geriatrics and Gerontology, Oncology and Genetics, having authored 15 papers that have together received 303 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (2 papers), Innovations in Medical Education (2 papers) and Pharmaceutical Practices and Patient Outcomes (2 papers). The work is most often cited by research in Oncology (127 citations), Dermatology (36 citations) and Immunology (66 citations). Philip D. Hall has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Mark Fenster, Thomas G. Olsen, Debra Frei‐Lahr, Donald R. Fleming, J Black, Bayard L. Powell, Ronald B. Gartenhaus, Arthur E. Frankel, Lawrence B. Afrin and Hermann Herbst. Their work appears in journals such as Cancer, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.